Delivery Order SPE2DB22D2009-SPE2DB24FM0NR

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a potential value of $10,673.50 and a completion date of January 30, 2024. This delivery order is part of a larger, single-award indefinite delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, which has a potential value of $2,134.70, is for the delivery of IPOL VIAL 5ML pharmaceutical products to support military treatment programs and facilities. The contract does not have a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4563752529 IPOL VIAL 5ML, a pharmaceutical product, with a potential value of $10,673.50 and a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also been awarded an indefinite delivery contract (IDC) by DLA with a potential...
This $80,412.48 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,470,416 units of the pharmaceutical product IPOL VIAL 5ML. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of...
This is a $8,567.19 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, with a performance period through June 13, 2025. AmerisourceBergen Drug Corp is a for-profit corporation registered in the System for Award Management (SAM) and has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $3,799.72 and a period of performance through May 30, 2025. This delivery order contract is on a firm-fixed-price basis, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, and has a firm fixed price ceiling value of $6,584.22. The contract is not set-aside and has a performance period extending through June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IPOL VIAL 5ML, a medical product, with a ceiling value of $1,090.10 and a period of performance ending on July 1, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,180.20, is for the delivery of IPOL VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price and is scheduled for completion by May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,694.00, is for the procurement of IPOL VIAL 5ML medical products. This is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of May 29, 2024. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FM0NR
    Delivery Order

This is a $2,561.64 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract is for the provision of IPOL VIAL 5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, in support of military treatment programs and facilities globally. This order does not have a set-aside designation. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen leverages its expertise and extensive supply chain network to fulfill government contracts, including those with the Department of Defense and Department of Veterans Affairs.

Generated 9/30/24, 4:58 PM